Use of Ultraviolet Cross-Linking for the Treatment of Thin Corneas in Keratoconus
- Authors: Bikbov M.M.1, Khalimov A.R.1, Babushkin A.E.1, Usubov E.L.1
-
Affiliations:
- Ufa Scientific Research Institute of Eye Diseases, Bashkir State Medical University
- Section: Reviews
- Submitted: 20.01.2025
- Accepted: 11.03.2025
- Published: 27.10.2025
- URL: https://kazanmedjournal.ru/kazanmedj/article/view/646295
- DOI: https://doi.org/10.17816/KMJ646295
- EDN: https://elibrary.ru/FDZRQP
- ID: 646295
Cite item
Abstract
Ultraviolet cross-linking of corneal collagen is an innovative technique designed to increase corneal strength in keratoconus by creating additional cross-links within the macromolecules of the extracellular matrix. The method is based on exposing the cornea to ultraviolet A radiation (370 nm) after saturation of the stroma with a photosensitizer (riboflavin). In the standard (Dresden) protocol—the conventional method of ultraviolet cross-linking—the minimum thickness of the de-epithelialized cornea must be at least 400 μm to prevent potential endothelial cell damage from a cytotoxic dose of ultraviolet radiation. However, in some patients with keratoconus, corneal thickness falls below this threshold, which limits the applicability of the standard clinical protocol. As a result, modified cross-linking techniques have been proposed for patients with thin corneas. This review presents various approaches developed to address this issue. In general, the safety and efficacy of modified techniques, including transepithelial, accelerated, intraoperative hypoosmotic swelling ones, or techniques involving contact lenses or donor corneal lens, have shown satisfactory outcomes: in most cases, corneal ectasia progression can be halted without serious postoperative complications. Nevertheless, each technique has its own advantages and limitations. The choice of technique depends on the resources of the clinic, the individual characteristics of the patient’s cornea, and the surgeon’s expertise. It should be noted that in practice modified cross-linking protocols for thin corneas are used much less frequently than the standard procedure, underscoring the need for further research to evaluate their clinical efficacy and safety.
About the authors
Mukharram M. Bikbov
Ufa Scientific Research Institute of Eye Diseases, Bashkir State Medical University
Email: niipriem@yandex.ru
ORCID iD: 0000-0002-9476-8883
SPIN-code: 4951-4615
Scopus Author ID: 6507082164
ResearcherId: AAO-7624-2021
MD, Dr. Sci. (Medicine), Professor, Director, Ufa Eye Research Institute
Russian Federation, UfaAzat R. Khalimov
Ufa Scientific Research Institute of Eye Diseases, Bashkir State Medical University
Author for correspondence.
Email: azrakhal@yandex.ru
ORCID iD: 0000-0001-7470-7330
SPIN-code: 7507-4450
Scopus Author ID: 57190189056
ResearcherId: AAR-3781-2021
Dr. Sci. (Biology), Head, scientific and innovative depart.
Russian Federation, UfaAlexander E. Babushkin
Ufa Scientific Research Institute of Eye Diseases, Bashkir State Medical University
Email: virologicdep@mail.ru
ORCID iD: 0000-0001-6700-0812
SPIN-code: 6146-0472
Scopus Author ID: 7006115027
MD, Dr. Sci. (Medicine), Head, depart. of research and development organization, Ufa Eye Research Institute
Russian Federation, UfaEmin L. Usubov
Ufa Scientific Research Institute of Eye Diseases, Bashkir State Medical University
Email: emines.us@inbox.ru
ORCID iD: 0000-0002-1008-1516
SPIN-code: 5265-2311
ResearcherId: MBV-9533-2025
MD, Cand. Sci. (Medicine), Head, depart. of corneal and lens surgery, Ufa Eye Research Institute
Russian Federation, UfaReferences
- Bikbov MM, Bikbova GM. Corneal ectasia. Moscow: Ophthalmology; 2011. 162 p. ISBN: 978-5-94289-056-8 EDN: QMBMML
- Singh RB, Koh S, Sharma N, et al. Keratoconus. Nat Rev Dis Primers. 2024;10(1):81. doi: 10.1038/s41572-024-00565-3 EDN: DNLTQI
- Deshmukh R, Ong Z, Rampat R, et al. Management of keratoconus: an updated review. Front Med. 2023:10:1212314. doi: 10.3389/fmed.2023.1212314 EDN: ABNFWQ
- Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–627. doi: 10.1016/s0002-9394(02)02220-1
- Zotov VV, Pashtaev NP, Pozdeeva NA. Corneal collagen cross-linking for keratoconus. Russian Annals of Ophthalmology. 2015;131(4):88–93. doi: 10.17116/oftalma2015131488-93
- Hafezi F, Kling S, Hafezi NL, et al. Corneal cross-linking. Prog Retin Eye Res. 2025:104:101322. doi: 10.1016/j.preteyeres.2024.101322 EDN: VNKSJQ
- Yang Q, Wang S, He Y, Zhang Y. The research progress on the molecular mechanism of corneal cross-linking in keratoconus treatment. Cont Lens Anterior Eye. 2023;46(2):101795. doi: 10.1016/j.clae.2022.101795 EDN: XFANVQ
- Bikbov MM, Khalimov AR, Usubov EL. Ultraviolet Corneal Crosslinking. Annals of the Russian Academy of Medical Sciences. 2016;71(3):224–232. doi: 10.15690/vramn562 EDN: WCZIDJ
- Deshmukh R, Hafezi F, Kymionis GD, et al. Current concepts in crosslinking thin corneas. Indian J Ophthalmol. 2019;67(1):8–15. doi: 10.4103/ijo.IJ0_1403_18 EDN: MEALGN
- Felter E, Khoramnia R, Friedrich M, et al. Biomechanical changes following corneal crosslinking in keratoconus patients. Graefes Arch Clin Exp Ophthalmol. 2024;262(11):3635–3642. doi: 10.1007/s00417-024-06549-z EDN: VNWSQY
- Eser NA, Dikmetas O, Kocabeyoglu S, et al. Evaluation of Keratoconus Disease with Tear Cytokine and Chemokine Levels Before and After Corneal Cross-Linking Treatment. Ocul Immunol Inflamm. 2024;32(3):269–275. doi: 10.1080/09273948.2023.2165950
- Wollensak G, Spoerl E, Reber F, Seiler T. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro. Eye. 2004;18:718–722. doi: 10.1038/sj.eye.6700751
- Padmanabhan P. Collagen cross-linking in thin corneas. Indian J Ophthalmol. 2013;61(8):422–424. doi: 10.4103/0301-4738.116073
- Kling S, Hafez F. Corneal Cross-Linking (CXL) In Thin Corneas: Theory, Experiments And Clinical Application. Point of view. East - West. 2017;1:17–19. EDN: YRUUZN
- Parker JS, van Dijk K, Melles GRJ. Treatment options for advanced keratoconus: A review. Surv Ophthalmol. 2015;60(5):459–480. doi: 10.1016/j.survophthal.2015.02.004
- Han Y, Xu Y, Zhu W, et al. Thinner corneas appear to have more striking effects of corneal collagen crosslinking in patients with progressive keratoconus. J Ophthalmol. 2017;2017:6490915. doi: 10.1155/2017/6490915
- Greenstein SA, Hersh PS. Update on corneal crosslinking for keratoconus and corneal ectasia. Curr Opin Ophthalmol. 2024;35(4):273–277. doi: 10.1097/ICU.0000000000001056 EDN: HGUQIZ
- Karamichos D, Nicholas SE, Khan A, Riaz KM. Collagen Crosslinking for Keratoconus: Cellular Signaling Mechanisms. Biomolecules. 2023;13(4):696. doi: 10.3390/biom13040696 EDN: OXOJVE
- Hafezi F. Corneal Cross-linking for Keratoconus: Exploring the Issues Regarding Accelerated Protocols and Thin Corneas. J Ophthalmic Vis Res. 2021;16(3):314–316. doi: 10.18502/jovr.v16i3.9425 EDN: THBHGE
- Cantemir A, Alexa A, Galan B, et al. Outcomes of iontophoretic corneal collagen crosslinking in keratoconic eyes with very thin corneas. Medicine Baltimore. 2017;96(47):e8758. doi: 10.1097/MD.0000000000008758 EDN: YEGTRZ
- Anisimova NS, Anisimov SI, Shilova NF, et al. Ultraviolet crosslinking in the treatment of keratoconus in patients with thin corneas. Russian Annals of Ophthalmology. 2020;136(2):99–106. doi: 10.17116/oftalma202013602199 EDN: NYRHJW
- Bikbov MM, Rusakova IuA, Usubov EL, Rakhimova EM. Crosslinking of Thin Corneas: a Modern Vision of the Problem. Literature Review. Acta biomedica scientifica. 2020;5(5):73–80. doi: 10.29413/ABS.2020-5.5.10 EDN: IOMYTS
- Tereshchenko AV, Trifanenkova IG, Golubeva YuYu, et al. Ultraviolet crosslinking of corneal collagen in patients with thin cornea. Literature review. Acta biomedica scientifica. 2021;6(6-1):229–236. doi: 10.29413/ABS.2021-6.6-1.26 EDN: BBIYGA
- Tereshchenko AV, Trifanenkova IG, Demianchenko SK, et al. Alternative methods of surgical treatment of keratoconus. Russian Annals of Ophthalmology. 2024;140(2):85–90. doi: 10.17116/oftalma202414002185 EDN: NLAQUF
- Borgardts K, Menzel-Severing J, Fischinger I, et al. Innovations in Corneal Crosslinking. Curr Eye Res. 2023;48(2):144–151. doi: 10.1080/02713683.2022.2146725 EDN: NBRTZI
- Franke MA, Landes T, Seiler T, et al. Corneal riboflavin gradients and UV-absorption characteristics after topical application of riboflavin in concentrations ranging from 0.1 to 0.5. Exp Eye Res. 2021;213:108842. doi: 10.1016/j.exer.2021.108842 EDN: GFLHUN
- Koppen C, Wouters K, Mathysen D, et al. Refractive and topographic results of benzalkonium chloride-assisted transepithelial crosslinking. J Cataract Refract Surg. 2012;38:1000–1005. doi: 10.1016/j.jcrs.2012.01.024
- Patent RUS № 175231 U1/ 11.28.2017. Bikbov MM, Usubov EL, Khalimov AR, et al. Device for corneal ionophoresis. (In Russ.) EDN: NWTXSL
- D'Oria F, Palazуn A, Alio JL. Corneal collagen cross-linking epithelium-on vs. epithelium-off: a systematic review and meta-analysis. Eye Vis. 2021;8(1):34. doi: 10.1186/s40662-021-00256-0 EDN: WXLJFE
- Soeters N, Wisse RP, Godefrooij DA, et al. Transepithelial versus epithelium off corneal cross-linking for the t reatment of progressive keratoconus: a randomized controlled trial. Am J Ophthalmol. 2015;159:821–828. doi: 10.1016/j.ajo.2015.02.005 EDN: UONNNB
- Spadea L, Mencucci R. Transepithelial corneal collagen cross-linking in ultrathin keratoconic corneas. Clin Ophthalmol. 2012;6:1785–1792. doi: 10.2147/opth.s37335
- Lin ZR, Wu HP, Luo SR, et al. Accelerated transepithelial corneal collagen crossinking for progressive keratoconus with a thin cornea: one-year results. Zhonghua Yan Ke Za Zhi. 2017;53(9):694–700. (In Chinese) doi: 10.3760/cma.j.issn.0412-4081.2017.09.011
- Khalimov AR. Precorneal riboflavin film in the corneal ultraviolet crosslinking system. ex vivo research. Medical Bulletin of Bashkortostan. 2017;12(1):65–68. EDN: YFUHNF
- Torres-Netto EA, Kling S, Hafezi N, et al. Oxygen diffusion may limit the biomechanical effectiveness of iontophoresis-assisted transepithelial corneal crossinking. J Refract Surg. 2018;34:768–774. doi: 10.3928/1081597X-20180830-01 EDN: WZOOOX
- Abdelkader SMH, Fernandez J, Rodrнguez-Vallejo M, et al. Comparison of Different Methods of Corneal Collagen Crosslinking: A Systematic Review. Semin Ophthalmol. 2021;36(3):67–74. doi: 10.1080/08820538.2021.1890784 EDN: GSNKEZ
- Vilares-Morgado R, Ferreira AM, Cunha AM, et al. Transepithelial Accelerated Crosslinking for Progressive Keratoconus: A Critical Analysis of Medium-Term Treatment Outcomes. Clin Ophthalmol. 2024;18:393–407. doi: 10.2147/OPTH.S450916 EDN: XEUITL
- Borchert GA, Kandel H, Watson SL. Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2024;262(6):1683–1692. doi: 10.1007/s00417-023-06287-8 EDN: OXCZVI
- Cehelyk EK, Syed ZA. Long-term outcomes of corneal crosslinking. Curr Opin Ophthalmol. 2024;35(4):315–321. doi: 10.1097/ICU.0000000000001054 EDN: IVBEDH
- Ahmad I, Gul N, Khan B, et al. Efficacy of transepithelial accelerated collagen cross linking in stopping the progression of keratoconus. J Ayub Med Coll Abbottabad. 2024;36(2):284–288. doi: 10.55519/JAMC-02-12672 EDN: PKIWMW
- Mazzotta C, Ramovecchi V. Customized epithelial debridement for thin ectatic corneas undergoing corneal cross-linking: epithelial island crosslinking technique. Clin Ophthalmol. 2014;8:1337–1343. doi: 10.2147/opth.s66372
- Cagil N, Can GD, Sarac O, Can ME. Outcomes of corneal collagen сrosslinking using a customized epithelial debridement technique in keratoconic eyes with thin corneas. Int Ophthalmol. 2017;37(1):103–109. doi: 10.1007/s10792-016-0234-3
- Ocak SY, Mangan MS, Elзioрlu MN. The Intraoperative Corneal Pachymetry Changes during Accelerated Corneal Cross-linking in Progressive Keratoconus Patients with Thin Corneas. Korean J Ophthalmol. 2021;35(6):438–442. doi: 10.3341/kjo.2021.0111 EDN: TDRVRY
- Samaras K, O'Brart DP, Doutch J, et al. Effect of epithelial retention and removal on riboflavin absorption in porcine corneas. J Refract Surg. 2009;25:771–775. doi: 10.3928/1081597X-20090813-03
- Anisimov SI, Anisimova SY, Mistryukov AS. Personalized (Local) UV-Crosslinking as a treatment of Keratoconus and corneal ectasia. Oftalmologia. 2017;14:195–199. doi: 10.18008/1816-5095-2017-3-195-199 EDN: ZHNPSL
- Сhoi M, Kim J, Kim EK, et al. Comparison of the Conventional Dresden Protocol and Accelerated Protocol With Higher Ultraviolet Intensity in Corneal Collagen Cross-Linking for Keratoconus. Cornea. 2017;36(5):523–529. doi: 10.1097/ICO.0000000000001165 EDN: YYEFLB
- Usubov EL, Mukhamadieva SR. Prospects for the development of corneal crosslinking technology (literature review). Point of view. East - West. 2018;1:130–132. doi: 10.25276/2410-1257-2018-1-130-132 EDN: XQJLPN
- Ozgurhan EB, Akcay BI, Kurt T, et al. Accelerated corneal collagen cross-linking in thin keratoconic corneas. J Refract Surg. 2015;31:386–390. doi: 10.3928/1081597X-20150521-11
- Kling S, Hafezi F. Biomechanical stiffening: Slow low-irradiance corneal crosslinking versus the standart Dresden protocol. J Cataract Refract Surg. 2017;43(7):975–979. doi: 10.1016/j.jcrs.2017.04.041
- Usubov EL, Khalimova LI. Localization of the stroma demarcation line after continuous and pulsed accelerated UV corneal crosslinking in patients with keratoconus. Modern technologies in ophthalmology. 2020;4(35):83–84. doi: 10.25276/2312-4911-2020-4-83-84 EDN: SBBQXE
- Knyazer B, Kormas RM, Chorny A, et al. Corneal Cross-linking in Thin Corneas: 1-Year Results of Accelerated Contact Lens-Assisted Treatment of Keratoconus. J Refract Surg. 2019;35(10):642–648. doi: 10.3928/1081597X-20190903-01
- Bikbov MM, Rusakova YuA, Usubov EL, Rakhimova EM. Accelerated crosslinking in thin cornea in patients with progressive keratoconus. Preliminary results. Point of view. East -West. 2020;2:9–13. doi: 10.25276/2410-1257-2020-2-9-13 EDN: NOSHMC
- Mazzotta C, Jacob S, Agarwal A, Kumar DA. In vivo confocal microscopy after contact lense-assisted corneal collagen cross-linking for thin keratoconic corneas. J Refract Surg. 2016;32(5):326–331. doi: 10.3928/1081597X-20160225-04
- Srivatsa S, Jacob S, Agarwal A. Contact lens assisted corneal cross linking in thin ectatic corneas — A review. Indian J Ophthalmol. 2020;68(12):2773–2778. doi: 10.4103/ijo.IJO_2138_20 EDN: YJBSUY
- Nour MM, El-Agha MH, Sherif AM, Shousha SM. Efficacy and Safety of Contact Lens-Assisted Corneal Crosslinking in the Treatment of Keratoconus With Thin Corneas. Eye Contact Lens. 2021;47(9):500–504. doi: 10.1097/ICL.0000000000000799 EDN: GKSERF
- Safalэ F, Ocak SY, Argon BD, et al. Evaluation of the results of contact lens assisted corneal cross-linking treatment in keratoconus patients with thin corneas. Jpn J Ophthalmol. 2024;68(3):225–232. doi: 10.1007/s10384-024-01055-5 EDN: ACESVL
- Patent RUS № 2735377 C1/ 10.30.2020. Bikbov MM, Khalimov AR, Kazakbayeva GM, et al. Method of ultraviolet corneal crosslinking taking into account topographic pachymetry and keratotopography in patients with thin cornea. EDN: XRIYTC
- Chen X, Stojanovic A, Eidet JR, Utheim TP. Corneal collagen cross-linking (CXL) in thin corneas. Eye and Vision. 2015;2:1–7. doi: 10.1186/s40662-015-0025-3 EDN: PRWABU
- Sachdev MS, Gupta D, Sachdev G, Sachdev R. Tailored stroma; expansion with a refractive lenticule for crosslinking the ultrathin cornea. J Cataract Refract Surg. 2015;41:918–923. doi: 10.1016/j.jcrs.2015.04.007
- Ganesh S, Brar S. Femtosecond intrastromal lenticular implantation combined with accelerated collagen cross-linking for the treatment of keratoconus - initial clinical result in 6 eyes. Cornea. 2015;10:86–95. doi: 10.1097/ico.0000000000000539
- Vasilyeva IV, Egorov VV, Vasilyev AB. Analysis of the effectiveness and safety of corneal collagen crosslinking in patients with a corneal thickness of less than 400 microns after deepithelization using a donor corneal lenticule. Practical medicine. 2017;1:9(110):25–28. EDN: ZITNEP
- Patent RUS № 2739995 C1/ 12.30.2020. Bikbov MM, Khalimov AR, Usubov ELO, Rusakova YuA. A method for conducting ultraviolet corneal crosslinking using biolinses for thin corneas. EDN: SZDYWD
- Bikbov MM, Кhalimov AR, Surkova VK, Kazakbaeva GM. Estimation of corneal thickness ex vivo and in vivo at instillation of photosensitizer solutions in different modifications of UV corneal crosslinking. RUDN Journal of Medicine. 2021;25(2):96–105. doi: 10.22363/2313-0245-2021-25-2-96-105 EDN: YMRTFE
- Koc M, Uzel MM, Koban Y, et al. Accelerated corneal cross-linking with a hypoosmolar riboflavin solution in keratoconic thin cornea: short-term results. Cornea. 2016;35:350–354. doi: 10.1097/ico.0000000000000701
- Patent RUS № 2631604 C1/ 09.25.2017. Bikbov MM, Khalimov AR, Bikbova GM, et al. A hypoosmotic ophthalmic agent for ultraviolet crosslinking of thin corneas. EDN: NSIWWD
- Buyuktepe TC, Ucakhan ОО. Long-term visual, refractive, tomographic and aberrometric outcomes of corneal collagen crosslinking (CXL) with or without hypoosmolar riboflavin solution in the treatment of progressive keratoconus patients with thin corneas. Graefes Arch Clin Exp Ophthalmol. 2022;260(4):1225–1235. doi: 10.1007/s00417-021-05314-w EDN: MHGYQK
- Abbondanza M, Wong ZSY, De Felice V, Abbondanza G. Customised Peripheral Corneal Cross-linking (P-CXL) for Ultra-thin Corneas with Stage III and IV Keratoconus. Semin Ophthalmol. 2023;38(7):630–637. doi: 10.1080/08820538.2023.2179407 EDN: HKLTPO
- Gu S-F, Fan Z-S, Wang L-H, et al. A short-term study of corneal collagen crossinking with hypo-osmolar riboflavin solution in keratoconic corneas. Int J Ophthalmol. 2015;8:94–97. doi: 10.3980%2Fj.issn.2222-3959.2015.01.17.
- Ocak YS, Mangan MS. Endothelial cell loss after accelerated corneal crosslinking using pachymetry-guided hypo-osmolar riboflavin dosing in thin keratoconic corneas. J Cataract Refract Surg. 2021;47(12):1530–1534. doi: 10.1097/j.jcrs.0000000000000686 EDN: TDHLKB
- Hafezi F. Limitation of collagen cross-linking with hypoosmolar riboflavin solution: failure in an extremely thin cornea. Cornea. 2011;30:917–919. doi: 10.1097/ico.0b013e31820143d1
- Ahearne M, Yang Y, Then KY, Liu KK. Non-destructive mechanical characterisation of UVA/riboflavin crosslinked collagen hydrogels. Br J Ophthalmol. 2008;92:268–271. doi: 10.1136/bjo.2007.130104
- Wollensak G, Spцrl E. Biomechanical efficacy of corneal cross-linking using hypoosmolar riboflavin solution. Eur J Ophthalmol. 2019;29(5):474–481. doi: 10.1177/1120672118801130
- Celik-Buyuktepe T, Ucakhan OO. Comparative Evaluation of Anterior Segment Optical Coherence Tomography Findings Following Accelerated Corneal Crosslinking Protocols Using Different Riboflavin Formulations and Soaking Durations. Curr Eye Res. 2025;50(1):32–40. doi: 10.1080/02713683.2024.2385441
- Gustafsson I, Olafsdottir T, Neumann О, et al. Early findings in a randomised controlled trial on crosslinking protocols using isoosmolar and hypoosmolar riboflavin for the treatment of progressive keratoconus. Acta Ophthalmol. 2025;103(1):23–32. doi: 10.1111/aos.16736 EDN: WSUZBY
Supplementary files

